FSWFX | GOFFX | FSWFX / GOFFX | |
Total Expense Ratio | 0.76 | 0.84 | 90% |
Annual Report Gross Expense Ratio | 0.76 | 0.84 | 90% |
Fund Existence | 5 years | 6 years | - |
Gain YTD | 9.856 | 6.045 | 163% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 80.3B | 2.4B | 3,350% |
Annual Yield % from dividends | 0.85 | 0.34 | 247% |
Returns for 1 year | 10.54 | 2.51 | 420% |
Returns for 3 years | 22.73 | -1.96 | -1,162% |
Returns for 5 years | N/A | -25.95 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SBHIX | 22.90 | 0.18 | +0.79% |
Saratoga Health & Biotechnology I | |||
OEGYX | 34.48 | -0.07 | -0.20% |
Invesco Discovery Mid Cap Growth Y | |||
MUERX | 36.03 | -0.13 | -0.36% |
MFS Blended Research Core Equity R1 | |||
VYSDX | 10.61 | -0.05 | -0.47% |
Voya Small Company R | |||
MXXIX | 60.91 | -0.47 | -0.77% |
Marsico Midcap Growth Focus Fund |